Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Gout”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01593527
What this trial is testing

Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease

Who this might be right for
Acute Gouty Arthritis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00663169
What this trial is testing

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

Who this might be right for
Arthritis, Gouty
Novartis 6
Large-scale testing (Phase 3)UnknownNCT02674776
What this trial is testing

Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout

Who this might be right for
Acute Gout
Quan Jiang 480
Not applicableStudy completedNCT04080570
What this trial is testing

Remote Physician Care for Home Hospital Patients

Who this might be right for
InfectionHeart FailureChronic Obstructive Pulmonary Disease+6 more
Brigham and Women's Hospital 172
Early research (Phase 1)Active Not RecruitingNCT07295496
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011

Who this might be right for
Acute Gout Flare
Innovent Biologics (Suzhou) Co. Ltd. 64
Early research (Phase 1)UnknownNCT06273813
What this trial is testing

Treatment of Topical Ketorolac Gel in Acute Gouty Flare

Who this might be right for
Acute Gouty ArthritisAcute PainGout Flare
Novilla Pharmaceuticals 30
Not applicableUnknownNCT04897113
What this trial is testing

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

Who this might be right for
HypercholesterolemiaHyperbilirubinemiaHyper IgE Syndrome+9 more
National Medical Research Center for Rehabilitation and Balneology 80
Large-scale testing (Phase 3)Looking for participantsNCT05658575
What this trial is testing

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Who this might be right for
Acute Gout FlareGout AttackGout Flare+4 more
Olatec Therapeutics, Inc. 300
Large-scale testing (Phase 3)Study completedNCT01356602
What this trial is testing

Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

Who this might be right for
Acute Gouty Arthritis
Novartis Pharmaceuticals 397
Large-scale testing (Phase 3)UnknownNCT06169891
What this trial is testing

Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Who this might be right for
Acute Gout
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 500
Testing effectiveness (Phase 2)Study completedNCT05328531
What this trial is testing

Clinical Study of Genakumab for Injection in Patients With Acute Gout

Who this might be right for
Acute Gout
Changchun GeneScience Pharmaceutical Co., Ltd. 121
Testing effectiveness (Phase 2)Study completedNCT00819585
What this trial is testing

The Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

Who this might be right for
Gout
Novartis Pharmaceuticals 432
Testing effectiveness (Phase 2)Looking for participantsNCT07453004
What this trial is testing

Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis

Who this might be right for
Acute Gouty Arthritis
TJ Biopharma Co., Ltd. 170
Large-scale testing (Phase 3)Looking for participantsNCT06863701
What this trial is testing

Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis

Who this might be right for
Gout ArthritisGout Attack
Laboratorios Silanes S.A. de C.V. 72
Early research (Phase 1)Study completedNCT06258213
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers

Who this might be right for
GoutAcute Gout FlareGout Flares
Atom Therapeutics Co., Ltd 90
Not applicableStudy completedNCT01151709
What this trial is testing

Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management

Who this might be right for
Gout
University of Massachusetts, Worcester 838
Not applicableWithdrawnNCT07493798
What this trial is testing

Serum Potassium Prediction Using Machine Learning and Single-lead ECG

Who this might be right for
InfectionHeart FailureChronic Obstructive Pulmonary Disease+6 more
Brigham and Women's Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07145229
What this trial is testing

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Who this might be right for
Acute Gouty ArthritisGout FlareGout Flares+1 more
Atom Therapeutics Co., Ltd 380
Not applicableActive Not RecruitingNCT07004231
What this trial is testing

Using Gout Buddy to Enhance Gout Management

Who this might be right for
Gout
SingHealth Polyclinics 110
Post-approval studies (Phase 4)Not Yet RecruitingNCT07661030
What this trial is testing

The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time

Who this might be right for
Gout
First Affiliated Hospital of Wenzhou Medical University 142
Next Page